Journal profile · Medicine-Hepatology
Clinical and Molecular Hepatology
ISSN 2287-2728 · eISSN 2287-285X · Korean Association for the Study of the Liver · SOUTH KOREA
Clinical and Molecular Hepatology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 21.22; fully open access; APC charged, amount not published; median 14 days to acceptance (94 articles, last 24 months); 261 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical and Molecular Hepatology is published by Korean Association for the Study of the Liver and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Liver Disease Diagnosis and Treatment, Hepatitis C virus research and Hepatitis B Virus Studies, together about 39.9% of its articles. Its main subfields are Hepatology. (generated from OpenAlex topic counts and CAS ranking data)
The Clinical and Molecular Hepatology, is an international, peer-reviewed, open- access journal published quarterly in English. The Clinical and Molecular Hepatology aims to share advanced and latest knowledge, trend, and understanding of hepatobiliary diseases, to provide a wide open academic forum for active debate and discussion among clinical doctors, translational researchers, and basic scientists, and to improve public health through a multidisciplinary approach, especially in resource-limited Asia-Pacific area with high prevalence of B viral infection and hepatocellular carcinoma. In addition, the Clinical and Molecular Hepatology gives priority to epidemiological studies of hepatobiliary diseases in East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America. The Clinical and Molecular Hepatology publishes original papers, meta-analysis, letter to editor, case reports, reviews, guidelines, editorials, and liver image and pathology on all aspects of the field of hepatology.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hepatology
Editor-in-chief Won Kim IndexedPublisher website
Editorial board by country: 6 in mainland China (about 5%); most named South Korea 60, Japan 9, United States 8, Mainland China 6, Taiwan, China 6 (114 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Liver Disease Diagnosis and TreatmentMedicine21.1%
- Hepatitis C virus researchMedicine9.6%
- Hepatitis B Virus StudiesMedicine9.2%
- Liver Disease and TransplantationMedicine7.9%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine7.5%
- Legal and Regulatory AnalysisSocial Sciences7%
- Linguistic, Cultural, and Literary StudiesSocial Sciences7%
- Military Technology and StrategiesEngineering7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Gastroenterology & Hepatology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPMCPubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 21.22LetPub ·
- Impact factor (publisher)
- 28.1Publisher website ·
- CiteScore 2026-06
- 28.1LetPub ·
- SJR 2026-06
- 4.94LetPub ·
- SNIP 2026-06
- 3.85LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 648OpenAlex ·
- 2-year mean citedness
- 7.07OpenAlex ·
- Self-citation rate
- 6.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 84LetPub ·
Articles by year OpenAlex count · 2,120 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 129 | 129 | 60 |
| 2025 | 261 | 261 | 833 |
| 2024 | 261 | 261 | 3,707 |
| 2023 | 113 | 113 | 3,391 |
| 2022 | 105 | 105 | 5,411 |
| 2021 | 55 | 55 | 1,937 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
14 daysMedian, submission to acceptance · P25–P75 7 days – 50 days
- Acceptance to online
- median 152 days (94 articles)
- Submission to online
- median 168 days
- Sample
- 94 articles with submission and acceptance dates (598 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | KRW 2,000,000 | No | CC BY-NC | |
| OpenAlex | KRW 42,000 | — | — | |
| LetPub | KRW 42,000 | No | — | |
| Publisher website | USD 1,000 / USD 1,500 / USD 2,000 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 1,000
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Keywords
- ≤ 5
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Required
- Not considered
- case report
Article types accepted12, with length limits
- correspondenceContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…main text ≤ 1,500 words
- editorialContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…main text ≤ 1,500 words
- editorialsContributions may be submitted as original articles, review articles, editorials and special topics.Length not stated
- letterContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- letter to the editorContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- letters to the editorContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- original articleContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- original articlesContributions may be submitted as original articles, review articles, editorials and special topics.Length not stated
- reviewContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- review articleContributions may be submitted as original articles, review articles, editorials and special topics. Special topics cover guidelines, meeting reports and hepato…Length not stated
- review articlesContributions may be submitted as original articles, review articles, editorials and special topics.Length not stated
- special topicsContributions may be submitted as original articles, review articles, editorials and special topics.Length not stated
Policy excerpts from the journal's websiteLicense & copyright, Peer review, Trial registration / reporting guidelines
- License & copyright Copyright Transfer
Copyright for all material published in the Clinical and Molecular Hepatology is vested in The Korean Association for the Study of the Liver. In accordance with the Copyright Act, all manuscripts must be accompanied by a Copyright transfer form signed by all authors and that follows these guidelines. Statements and opinions expressed in the articles and communications in the Clinical and Molecular…
Source ↗Publisher website ·- Peer review Peer Review and Publishing
Blind peer review Model summary
The journal utilizes blind peer-review in evaluating manuscripts for publication. Submitted papers will be reviewed by at least two referees, and decisions will be available in approximately one months. With respect to the revision and resubmission of manuscripts, it is the journal’s policy to allow a couple of resubmission only, which should be received within 2 months from the time of receipt of…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting Guidelines
Clinical and Molecular Hepatology endorses the use of appropriate reporting guidelines when preparing health research manuscripts. In accordance with the ICMJE Recommendations, authors should follow reporting guidelines for specific study designs. Relevant reporting guidelines and checklists are available through the EQUATOR Network (https://www.equator-network.org/). For manuscripts that receive …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Association for the Study of the Liver
- Country or region
- SOUTH KOREA
- Language
- English
- ISSN
- 2287-2728
- Electronic ISSN
- 2287-285X
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical and Molecular Hepatology
What CAS zone is Clinical and Molecular Hepatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Molecular Hepatology is in Zone 1 of Medicine, and in Zone 1 of the minor category Gastroenterology & Hepatology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Molecular Hepatology?
The latest impact factor listed by LetPub is 21.22; CiteScore 28.1, h-index 86.
How long does peer review take at Clinical and Molecular Hepatology?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 14 days (interquartile range 7–50 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical and Molecular Hepatology?
According to the journal's author guidelines: Keywords: ≤ 5; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical and Molecular Hepatology based?
Of the 114 board members whose country the journal's board page names, 6 (about 5%) are in mainland China; the countries named most often are South Korea (60), Japan (9) and United States (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Molecular Hepatology?
According to LetPub and DOAJ records, Clinical and Molecular Hepatology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PMC and PubMed; that list has not been checked against each database.
Is Clinical and Molecular Hepatology open access, and what is the APC?
Clinical and Molecular Hepatology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .